Ireland· IE-PA-PA23266/015/002

Germentin 125 mg/31.25 mg per 5 ml Powder for Oral Suspension

A amoxicillin und beta-lactamase-inhibitor product containing clavulanic acid + amoxicillin, registered in Ireland by Viatris Limited. The same ATC class is registered in 13 of our 19 countries.

ATC J01CR02

Checked against HPRA (Ireland) on September 28, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about clavulanic acid + amoxicillinAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Amoxicillin und beta-lactamase-inhibitor is registered in 13 of 19 countries.

Countries holding a registration under ATC J01CR02 (amoxicillin und beta-lactamase-inhibitor), each read from that country’s own register.

This record: Ireland, from HPRA (Ireland)
9 of them publish a price we can compare per daily dose

Search amoxicillin und beta-lactamase-inhibitor products by name

Amoxicillin und beta-lactamase-inhibitor · ATC J01CR02

13 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Icelandprice
Ireland
Italyprice
Netherlands
Norwayprice
Polandprice
Spainprice
Switzerlandprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of amoxicillin und beta-lactamase-inhibitor costs, country by country.

Normalised to the WHO defined daily dose (1.5 g), the median price runs from $1.28 in Italy to $5.60 in Switzerland — a ×4.4 gap.

4 markets with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Amoxicillin und beta-lactamase-inhibitor · price per daily dose (1.5 g)

USD · FX 28 Sept 2026

CH Switzerland$5.60
ES Spain$4.65
CZ Czechia$1.42
IT Italy$1.28

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

HPRA (Ireland)

Active substance: Clavulanic acid + Amoxicillin
Manufacturer: Viatris Limited
Country: Ireland (IE)
ATC code: J01CR02
ATC class: Amoxicillin und Beta-Lactamase-Inhibitor
Defined daily dose: 1.5 g, O
Reimbursed: Not published by this register
Source register: HPRA (Ireland)
Last checked: September 28, 2026

Packs & prices · 1

ie_pa_number
PA23266/015/002

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

24 interactions on record for amoxicillin und beta-lactamase-inhibitor.

Graded by severity as the source publishes them — 4 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check amoxicillin und beta-lactamase-inhibitor against other medicines How interaction checks work

Amoxicillin und beta-lactamase-inhibitor · interactions on record

24 records

4 severe
17 moderate

Most severe, free to view

LeflunomidL04AA13severe
TeriflunomidL04AA31severe
LeflunomideL04AK01severe
TeriflunomideL04AK02severe

3 more interactions with mechanism and management, from a commercially licensed source.

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Amoxicillin und beta-lactamase-inhibitor in 12 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All amoxicillin und beta-lactamase-inhibitor products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

Austria · Amcladoz, Amclavu
Belgium · Amoclane, Amoclaneeg
Bulgaria · Amoksiklav Es, Aмоксигамма
Cyprus · Augmentin, Augmentin Es
Czechia · Amoksiklav, Amoxicillin/Clavulanic Acid Aptapharma
Germany · Amoclan, Amoclav
Denmark · Amoxicillin/Clavulansyre Aurobindo, Baxumil
Estonia · Amoksiklav, Amoxicillin/Clavulanic Acid Auxilia
Spain · Amoxicilina / Ácido Clavulánico Pensa Pharma, Amoxicilina/Ácido Clavulánico Almus
Finland · Amorion Comp, Amoxicillin/Clavulanic Acid Bioglan
France · Amoxicillin / Clavulanic Acid Reig Jofre, Amoxicillin/Acide Clavulanique Zydus France
United Kingdom (Northern Ireland) · Augmentin, Augmentin Duo
Greece · Augmentin, Augmentin Mf (Γεύση Φρούτων)
Croatia · Amoksicilin/Klavulanska Kiselina Antibiotice, Amoksicilin/Klavulanska Kiselina Aptapharma
Hungary · Aksolin, Aktil
Iceland · Amoxicillin/Clavulanic Acid Normon, Spectracillin
Italy · Abba, Abioclav
Lithuania · Amoksiklav, Amoxicillin/Clavulanic Acid Antibiotice
Luxembourg · Amoclane, Amoxiclav
Latvia · Amoksiklav, Amoxicillin/Clavulanic Acid
Malta · Amoxi-Clavulan, Amoxicillin/Clavulanic Acid Aptapharma
Netherlands · Amoxicillin/Clavulanic Acid Aurobindo, Amoxicilline/Clavulaanzuur
Norway · Augmentin, Augmentin Blandet Fruktsmak
Poland · Amoclan, Amoksiklav
Portugal · Agmalife, Agmalife Bid
Romania · Amoksiklav, Amoksiklav Quicktab
Sweden · Amoxicillin/Clavulanic Acid Aurobindo, Amoxicillin/Clavulanic Acid Bb
Slovenia · Amoksicilin/Klavulanska Kislina Antibiotice, Amoksicilin/Klavulanska Kislina Aptapharma
Slovakia · Amoksiklav, Amoksiklav 2 X

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/bb2378d4-ff39-4e83-8f51-24392c4a57f3
GET /v1/drugs/bb2378d4-ff39-4e83-8f51-24392c4a57f3?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Powder for oral suspension",
  "routes": [
    "Oral use"
  ],
  "source": "hpra",
  "atc_all": [
    "J01CR",
    "J01CR02"
  ],
  "strength": null,
  "pa_number": "PA23266/015/002",
  "substances": [
    "Clavulanic acid",
    "Amoxicillin"
  ],
  "legal_basis": "Generic application (Article 10(1) of Directive No 2001/83/EC)",
  "market_info": "Marketed",
  "authorised_at": "05/03/2004",
  "dispensing_status": "Product subject to prescription which may not be renewed (A)",
  "registration_status": "AU",
  "supply_legal_status": "Supply through pharmacies only",
  "interchangeable_code": "IC0037-071-034"
}

API reference MCP server Plans

See everything about amoxicillin und beta-lactamase-inhibitor.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console